Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
57th Scientific Session of the American College of Cardiology
Determining the Atherosclerosis Regression Point Through LDL Levels and Quantitative Coronary Angiography
Chicago, Illinois / March 29-April 1, 2008
Chicago - New data presented at the ACC late-breaking session confirm a milestone in understanding control of cardiovascular disease through treatment of lipids. An analysis with quantitative coronary angiography (QCA), like a previous...
57th Annual Scientific Sessions of the American College of Cardiology
ENHANCE: Lipid Lowering Treatment Beyond Statins
Chicago, Illinois / March 29 - April 1, 2008
Chicago - In a study conducted in patients with familial hypercholesterolemia, additional lipid lowering with combination therapy did not produce an anticipated regression in carotid intima media thickness. While this result was unexpected,...
57th Annual Scientific Sessions of the American College of Cardiology
ONTARGET: Encouraging Findings for the High-risk Cardiovascular Population
Chicago, Illinois / March 29-April 1, 2008
Chicago - The long-awaited results of the ONTARGET study, which randomized more than 25,000 patients, demonstrated that an angiotensin receptor blocker (ARB) achieves the same degree of protection against cardiovascular events in high-risk...
MEDICAL OPTIONS Cardiovascular Risk Factors
The Kidney-Heart-Brain Axis: Update on RAS Inhibition
February 2008
The Essence of RAS Inhibition in Hypertension Dr. Lyall Higginson, Royal Jubilee Hospital The Renin-angiotensin System in Diabetes Dr. Sheldon Tobe, University of Toronto Maximizing Nephroprotection: The Role of RAS Inhibition Dr. Paul René...
JOURNAL CLUB - CARDIOLOGY
From Prehypertension to End-stage Disease: Effectively Controlling Blood Pressure and Preventing Target Organ Damage
January 2008
EDITORIAL OVERVIEW Jonathan Howlett, MD Dalhousie University Halifax, Nova Scotia PANEL Pierre Nantel, MD Centre hospitalier Sorel-Tracy Sorel-Tracy, Quebec Michel White, MD Université de Montréal Montreal, Quebec Norman...
80th Scientific Sessions of the American Heart Association
Evolving Antiplatelet Strategies for Percutaneous Coronary Intervention
Orlando, Florida / November 5, 2007
Numerous studies have confirmed the central role of platelets in complications after percutaneous coronary intervention (PCI). The wealth of data provided the impetus for development of aggressive antiplatelet regimens for patients...
80th Scientific Sessions of the American Heart Association
Focus on New Antiarrhythmics: Fulfilling an Unmet Need
Orlando, Florida / November 4-7, 2007
Orlando - Atrial fibrillation (AF) is associated with increased morbidity and mortality, primarily from stroke and exacerbation of heart failure. Currently available antiarrhythmic agents indiscriminately block ion channels in the heart and...
80th Scientific Sessions of the American Heart Association
Important New Insights into the Use of Statins in Heart Failure
Orlando, Florida / November 4-7, 2007
Orlando - The first major multinational statin trial has provided critical new insight into the relative importance of pathophysiologic mechanisms for cardiovascular (CV) event reduction in patients with heart failure. The double-blind,...
80th Scientific Sessions of the American Heart Association
Clinical Issues in the Management of ST-Elevation Myocardial Infarction
Orlando, Florida / November 4-7, 2007
INTRODUCTION Despite the emergence of new agents, interventions and therapeutic strategies, antithrombin therapy remains central to the management of patients with acute coronary syndromes (ACS) and ST-segment elevation myocardial...